FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.7  |  FHIR Version n/a  User: [n/a]

900000000000526001: REPLACED BY association reference set (foundation metadata concept)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT model component module (core metadata concept)

Descriptions:

Id Description Lang Type Status Case? Module
900000000001156010 REPLACED BY association reference set (foundation metadata concept) en Fully specified name Active Entire term case sensitive (core metadata concept) SNOMED CT model component module (core metadata concept)
900000000001157018 REPLACED BY association reference set en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT model component module (core metadata concept)


14853 members. Search Members:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
REPLACED BY association reference set (foundation metadata concept) Is a Historical association reference set (foundation metadata concept) true Inferred relationship Some

Members targetComponentId
Hodgkin's disease, lymphocytic depletion of lymph nodes of axilla and upper limb Hodgkin disease, lymphocytic depletion of lymph nodes of upper limb (disorder)
Hodgkin's disease, lymphocytic depletion of lymph nodes of head, face and neck Hodgkin lymphoma, lymphocyte depletion of lymph nodes of head and neck (disorder)
Hodgkin's disease, lymphocytic depletion of lymph nodes of inguinal region AND/OR lower limb Hodgkin disease, lymphocytic depletion of lymph nodes of lower limb (disorder)
Hodgkin's disease, lymphocytic depletion of lymph nodes of inguinal region and lower limb Hodgkin disease, lymphocytic depletion of lymph nodes of lower limb (disorder)
Hodgkin's disease, lymphocytic predominance Hodgkin lymphoma, lymphocyte-rich
Hodgkin's disease, lymphocytic predominance, diffuse Hodgkin lymphoma, lymphocyte-rich
Hodgkin's disease, lymphocytic-histiocytic predominance of extranodal AND/OR solid organ site Hodgkin lymphoma, lymphocyte-rich (disorder)
Hodgkin's disease, lymphocytic-histiocytic predominance of lymph nodes of axilla AND/OR upper limb Hodgkin disease, lymphocytic-histiocytic predominance of lymph nodes of upper limb (disorder)
Hodgkin's disease, lymphocytic-histiocytic predominance of lymph nodes of axilla and upper limb Hodgkin disease, lymphocytic-histiocytic predominance of lymph nodes of upper limb (disorder)
Hodgkin's disease, lymphocytic-histiocytic predominance of lymph nodes of inguinal region AND/OR lower limb Hodgkin disease, lymphocytic-histiocytic predominance of lymph nodes of lower limb
Hodgkin's disease, lymphocytic-histiocytic predominance of lymph nodes of inguinal region and lower limb Hodgkin disease of lymph nodes of lower limb (disorder)
Hodgkin's disease, mixed cellularity of extranodal AND/OR solid organ site Hodgkin's disease, mixed cellularity (clinical)
Hodgkin's disease, mixed cellularity of lymph nodes of axilla AND/OR upper limb Hodgkin disease, mixed cellularity of lymph nodes of upper limb (disorder)
Hodgkin's disease, mixed cellularity of lymph nodes of axilla and upper limb Hodgkin disease, mixed cellularity of lymph nodes of upper limb (disorder)
Hodgkin's disease, mixed cellularity of lymph nodes of inguinal region AND/OR lower limb Hodgkin disease, mixed cellularity of lymph nodes of lower limb (disorder)
Hodgkin's disease, mixed cellularity of lymph nodes of inguinal region and lower limb Hodgkin disease, mixed cellularity of lymph nodes of lower limb (disorder)
Hodgkin's disease, nodular sclerosis of extranodal AND/OR solid organ site Hodgkin's disease, nodular sclerosis (clinical)
Hodgkin's disease, nodular sclerosis of lymph nodes of axilla AND/OR upper limb Hodgkin disease, nodular sclerosis of lymph nodes of upper limb
Hodgkin's disease, nodular sclerosis of lymph nodes of axilla and upper limb Hodgkin disease, nodular sclerosis of lymph nodes of upper limb
Hodgkin's disease, nodular sclerosis of lymph nodes of inguinal region AND/OR lower limb Hodgkin disease, nodular sclerosis of lymph nodes of lower limb (disorder)
Hodgkin's disease, nodular sclerosis of lymph nodes of inguinal region and lower limb Hodgkin disease, nodular sclerosis of lymph nodes of lower limb (disorder)
Hodgkin's disease, nodular sclerosis, mixed cellularity Hodgkin lymphoma, nodular sclerosis, grade 1 (morphologic abnormality)
Hodgkin's granuloma of extranodal AND/OR solid organ site Hodgkin's granuloma (clinical)
Hodgkin's granuloma of lymph nodes of axilla AND/OR upper limb Hodgkin granuloma of lymph nodes of upper limb (disorder)
Hodgkin's granuloma of lymph nodes of axilla and upper limb Hodgkin granuloma of lymph nodes of upper limb (disorder)
Hodgkin's granuloma of lymph nodes of inguinal region AND/OR lower limb Hodgkin granuloma of lymph nodes of lower limb
Hodgkin's granuloma of lymph nodes of inguinal region and lower limb Hodgkin granuloma of lymph nodes of lower limb
Hodgkin's paragranuloma Hodgkin lymphoma, nodular lymphocyte predominance (clinical)
Hodgkin's paragranuloma Hodgkin lymphoma, nodular lymphocyte predominance
Hodgkin's paragranuloma of extranodal AND/OR solid organ site Hodgkin lymphoma, nodular lymphocyte predominance (clinical)
Hodgkin's paragranuloma of lymph nodes of axilla AND/OR upper limb Hodgkin paragranuloma of lymph nodes of upper limb (disorder)
Hodgkin's paragranuloma of lymph nodes of axilla and upper limb Hodgkin paragranuloma of lymph nodes of upper limb (disorder)
Hodgkin's paragranuloma of lymph nodes of inguinal region AND/OR lower limb Hodgkin's paragranuloma of lymph nodes of lower limb (disorder)
Hodgkin's paragranuloma of lymph nodes of inguinal region and lower limb Hodgkin's paragranuloma of lymph nodes of lower limb (disorder)
Hodgkin's sarcoma of extranodal AND/OR solid organ site Hodgkin's sarcoma (disorder)
Hodgkin's sarcoma of lymph nodes of axilla AND/OR upper limb Hodgkin sarcoma of lymph nodes of upper limb (disorder)
Hodgkin's sarcoma of lymph nodes of axilla and upper limb Hodgkin sarcoma of lymph nodes of upper limb (disorder)
Hodgkin's sarcoma of lymph nodes of inguinal region AND/OR lower limb Hodgkin sarcoma of lymph nodes of lower limb (disorder)
Hodgkin's sarcoma of lymph nodes of inguinal region and lower limb Hodgkin sarcoma of lymph nodes of lower limb (disorder)
Holborn sentence reading test Holborn Reading Scale (assessment scale)
Holmes Gang syndrome X-linked intellectual disability hypotonic face syndrome
Homatropine hydrobromide 0.125% eye drops Product containing precisely homatropine hydrobromide 1.25 milligram/1 milliliter conventional release eye solution (clinical drug)
Homatropine hydrobromide 0.25% eye drops Homatropine hydrobromide 2.5 mg/mL eye solution
Homatropine hydrobromide 0.5% eye drops Homatropine hydrobromide 5 mg/mL eye solution
Homatropine hydrobromide 5% eye drops Homatropine hydrobromide 50 mg/mL eye solution
Homatropine hydrobromide 5%/mL solution Homatropine hydrobromide 50 mg/mL eye solution
Home manager (housewife) Home manager
Home nebulizer used since last appointment Home nebulizer used since last encounter
Homodigital finger flap Flap (substance)
Hongiella mannitolivorans Algoriphagus mannitolivorans (organism)
Hordeolum internum Internal hordeolum (disorder)
Hormone level in specimen from female genital organ outside reference range Female sex hormone outside reference range
Hormone substitute Product containing hormone (product)
Horse allergy vaccine Horse allergy vaccine
Horseradish - dietary Horseradish (substance)
Horseradish - dietary Horseradish (substance)
Hospital physicist Medical physicist
Hospital physicist Medical physicist
Hot comb alopecia Central centrifugal cicatricial alopecia (disorder)
environnement chaud Hot environment
Hottentot Khoikhoi
Hottentot language Khoisan language
House dust allergy vaccine House dust allergy vaccine (product)
House mite allergy vaccine House mite allergy vaccine (product)
Human adenovirus 40 antigen Antigen of Human mastadenovirus F (substance)
Human adenovirus 41 antigen Antigen of Human mastadenovirus F (substance)
Human alpha1 proteinase inhibitor 1000mg powder for injection solution vial Human alpha1 proteinase inhibitor 1 g powder for solution for injection vial
Human alpha1 proteinase inhibitor 500mg injection solution vial + diluent Human alpha1 proteinase inhibitor 500 mg powder for solution for injection vial
Human alpha1 proteinase inhibitor 500mg powder for conventional release solution for injection vial Human alpha1 proteinase inhibitor 500 mg powder for solution for injection vial
Human chorionic gonadotropin 10,000iu powder and solvent for injection solution vial Product containing precisely human chorionic gonadotropin 10000 unit/1 vial powder for conventional release solution for injection (clinical drug)
Human coronavirus HK1 Human coronavirus HKU1
Human herpesvirus 1 group virus Simplexvirus
Human herpesvirus 3 group virus Genus Varicellovirus (organism)
Human immunodeficiency virus Human immunodeficiency virus Centers for Disease Control and Prevention stage 1 (finding)
Human immunodeficiency virus (HIV) infection category B1 Human immunodeficiency virus Centers for Disease Control and Prevention stage 1 (finding)
catégorie A1 d'infection au VIH des Centres for Disease Control and Prevention Human immunodeficiency virus Centers for Disease Control and Prevention stage 1 (finding)
catégorie B1 d'infection au VIH des Centres for Disease Control and Prevention Human immunodeficiency virus Centers for Disease Control and Prevention stage 1 (finding)
catégorie C1 d'infection au VIH des Centres for Disease Control and Prevention (SIDA) Human immunodeficiency virus Centers for Disease Control and Prevention stage 1 (finding)
stade I d'infection au VIH selon la classification de l'Organisation mondiale de la Santé World Health Organization 2007 Human immunodeficiency virus infection clinical stage 1
stade II d'infection au VIH selon la classification de l'Organisation mondiale de la Santé World Health Organization 2007 Human immunodeficiency virus infection clinical stage 2
stade III d'infection au VIH selon la classification de l'Organisation mondiale de la Santé World Health Organization 2007 Human immunodeficiency virus infection clinical stage 3 (finding)
stade IV d'infection au VIH selon la classification de l'Organisation mondiale de la Santé (SIDA) World Health Organization 2007 Human immunodeficiency virus infection clinical stage 4 (finding)
classification du VIH par l'Organisation mondiale de la santé World Health Organization human immunodeficiency virus infection clinical stage (finding)
séropositivité au VIH Human immunodeficiency virus detected (finding)
Human immunodeficiency virus type 2 Human immunodeficiency virus type 2
Human immunodeficiency virus type I Human immunodeficiency virus type I
Human immunodeficiency virus, type II glycoprotein 53 antibody Human immunodeficiency virus 2 protein 53 antibody (substance)
parodontite associée au virus de l'immunodéficience humaine Periodontitis exacerbated by human immunodeficiency virus infection (disorder)
Human immunoglobulin IgG 200mg/mL solution for injection Product containing only human immunoglobulin G (medicinal product)
immunoglobuline humaine G à 10 %, flacon de solution injectable Product containing only human immunoglobulin G (medicinal product)
immunoglobuline humaine G, flacon de 10 g d'une solution injectable Product containing only human immunoglobulin G (medicinal product)
immunoglobuline humaine G, flacon de 10 g d'une poudre pour solution injectable Product containing only human immunoglobulin G (medicinal product)
immunoglobuline humaine G à 16 %, flacon de solution injectable Product containing precisely human immunoglobulin G 160 milligram/1 milliliter conventional release solution for injection (clinical drug)
immunoglobuline humaine G, flacon de 2,5 g d'une poudre pour solution injectable Product containing only human immunoglobulin G (medicinal product)
immunoglobuline humaine G, flacon de 20 g d'une solution injectable Product containing only human immunoglobulin G (medicinal product)
immunoglobuline humaine G, flacon de 5 g d'une poudre pour solution injectable Product containing only human immunoglobulin G (medicinal product)
Human insulin 1mg unit dose blister dry powder for inhalation Human insulin-containing product
Human insulin 3mg unit dose blister dry powder for inhalation Human insulin-containing product
Human interferon gamma-1b 200 micrograms/mL injection solution 0.5mL vial Interferon gamma-1b 200 microgram/mL solution for injection
Human interferon gamma-1b adverse reaction Adverse reaction to interferon gamma-1b
Human leukocyte antigen A 3101 present Human leukocyte antigen A*31:01 detected (finding)

Start Previous Page 54 of 149 Next End


Reference Sets

Reference set descriptor

Back to Start